EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 166 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $280,000 | -62.7% | 6,700 | -58.4% | 0.00% | -100.0% |
| Q4 2020 | $750,000 | +13.1% | 16,100 | +16.6% | 0.00% | 0.0% |
| Q2 2020 | $663,000 | +5.1% | 13,813 | +0.7% | 0.00% | -50.0% |
| Q1 2020 | $631,000 | -61.3% | 13,713 | -49.4% | 0.00% | -50.0% |
| Q4 2019 | $1,630,000 | +434.4% | 27,127 | +573.1% | 0.00% | +300.0% |
| Q2 2018 | $305,000 | -30.7% | 4,030 | -51.7% | 0.00% | 0.0% |
| Q1 2018 | $440,000 | -95.3% | 8,348 | -95.3% | 0.00% | -95.7% |
| Q4 2017 | $9,412,000 | -26.9% | 176,186 | -18.4% | 0.02% | -32.4% |
| Q3 2017 | $12,882,000 | +4567.4% | 215,995 | +6071.3% | 0.03% | +3300.0% |
| Q2 2017 | $276,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |